The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Open accessAbstract
Lipid homeostasis in vertebrate cells is regulated by a family of membrane-bound transcription factors designated sterol regulatory element-binding proteins (SREBPs).SREBPs directly activate the expression of more than 30 genes dedicated to the synthesis and uptake of cholesterol, fatty acids, triglycerides, and phospholipids, as well as the NADPH cofactor required to synthesize these molecules (1-4).In the liver, three SREBPs regulate the production of lipids for export into the plasma as lipoproteins and into the bile as micelles.The complex, interdigitated roles of these three SREBPs have been dissected through the study of ten different lines of gene-manipulated mice.These studies form the subject of this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By contrast, Srebp-1c is transcribed at extremely high levels in response to insulin (6, 28)”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As SREBPs contain an SRE in their promoter region, they induce their own expression in a positive feedback mechanism4,18.”
From Haploid genetic screens identify SPRING/C12ORF49 as a determinant of SREBP signaling and cholesterol metabolism (2020) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An additional level of regulation of the genes involved in cholesterol uptake and synthesis is provided by SREBP signaling, in which low cellular sterol levels lead to the SCAP-mediated trafficking of SREBP proteins from the ER to the Golgi, where they are cleaved by resident proteases (encoded by MBTPS1 and MBTPS2) to release and activate their transcription factor domains[7,8].”
From Genome-scale CRISPR screening for modifiers of cellular LDL uptake (2021) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“likely due to overlapping functions allowing one gene to compensate for loss of the other[7]”
From Genome-scale CRISPR screening for modifiers of cellular LDL uptake (2021) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Two transcription factor families with opposing actions – the liver-X receptors (LXRs) and the sterol regulatory element-binding proteins (SREBPs) – are the main orchestrators of this balance (Hong and Tontonoz, 2014; Horton et al., 2002).”
From Inhibition of cholesterol biosynthesis through RNF145-dependent ubiquitination of SCAP (2017) · cites this paper as Horton et al., 2002
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the liver, SREBP1c is the prominent SREBP1 isoform and primarily controls fatty acid synthesis and mobilization, while SREBP2 controls cholesterol biosynthesis and lipoprotein uptake [12,13].”
From Loss of the E3 ubiquitin ligase MARCHF6 alters hepatic lipid metabolism and drives spontaneous hepatosteatosis (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The intracellular cholesterol economy is largely regulated by the sterol response element binding protein (SREBPs), a group of transcription factors that regulate genes involved in the biosynthesis of cholesterol and fatty acids (13).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“SREBP1a and SREBP1c are responsible for fatty acid metabolism and SREBP2 primarily for cholesterol synthesis through increasing the expression of HMG-CoA reductase (HMGCR) [32].”
From HIV-TAT dysregulates microglial lipid metabolism through SREBP2/miR-124 axis: Implication of lipid droplet accumulation microglia in NeuroHIV (2025) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“However, SREBPs not only activate cholesterol synthesis but also fatty acid and phospholipid synthesis (2).”
From Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation* (2010) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Genes involved in its synthesis are coordinately up-regulated by the action of SREBP transcription factors (2).”
From Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation* (2010) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“SREBP-1c regulates the transcription of genes involved in fatty acid metabolism, such as fatty acid synthase (FASN) (5–7).”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“SREBP-2 regulates the transcription of cholesterol-related genes, such as 3-hydroxy-3-methylglutaryl CoA reductase (HMGCR), which catalyzes a rate-limiting step in cholesterol biosynthesis, and the low-density lipoprotein receptor (LDLr), which imports cholesterol from the blood (5–7).”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“The sterol-regulatory element binding proteins (SREBP) are central transcriptional regulators of lipid metabolism.”
From Haploid genetic screens identify SPRING/C12ORF49 as a determinant of SREBP signaling and cholesterol metabolism (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“The SREBP pathway is activated when cellular cholesterol levels decline as a means to increase cholesterol synthesis and uptake (4).”
From A MARCH6 and IDOL E3 Ubiquitin Ligase Circuit Uncouples Cholesterol Synthesis from Lipoprotein Uptake in Hepatocytes (2016) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“The released N-terminal SREBP-1 and −2 transcriptional domains translocate to the nucleus to activate transcriptional programs that promote fatty acid and cholesterol biosynthesis, respectively8.”
From Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans (2023) · cites this paper as [8]
In the citing paper
“The cellular signal driving this increased hepatic de novo lipogenesis can most likely be attributed to hyperinsulinemia promoting increased expression of the sterol regulatory element binding protein-1c in the liver, which coordinately regulates transcription of all of the key enzymes involved in lipogenesis (24).”
From The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome (2007) · cites this paper as [24]
In the citing paper
“Recently, 2 additional transcription factors, X-box binding protein 1 (XBP1) and CHO response element-binding protein (ChREBP), have been identified as inducers of hepatic lipogenesis in response to ingested CHOs (eg, fructose and glucose) that is independent of insulin.431,432”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [431]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Self-citationNonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Repa, J. J., Liang, G., Ou, J., Bashmakov, Y. K., Lobaccaro, J. A., Shimomura, I., Shan, B., Brown, M. S., Goldstein, J. L., & Mangelsdorf, D. J. (2000) · Genes & Development · doi:10.1101/gad.844900 · Cited by 1,724
Self-citationLeptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038
Self-citationStructural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ
Janowski, B. A., Grogan, M. J., Jones, S. A., Wisely, G. B., Kliewer, S. A., Corey, E. J., & Mangelsdorf, D. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.266 · Cited by 946
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
Self-citationShimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., & Goldstein, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118951 · Cited by 817
Self-citationJoseph, S. B., Laffitte, B. A., Patel, P. H., Watson, M. A., Matsukuma, K. E., Walczak, R., Collins, J. L., Osborne, T. F., & Tontonoz, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111041200 · Cited by 795
Kim, J. B., Sarraf, P., Wright, M., Yao, K., Mueller, E., Solanes, G., Lowell, B. B., & Spiegelman, B. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1411 · Cited by 792
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,040
Biddinger, S. B., Miyazaki, M., Boucher, J., Ntambi, J. M., & Kahn, C. R. (2006) · Diabetes · doi:10.2337/db05-0742 · Cited by 107
Zhou, H., Pandak, W. M., Lyall, V., Natarajan, R., & Hylemon, P. B. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012898 · Cited by 106
Atypical Antipsychotics Alter Cholesterol and Fatty Acid Metabolism in Vitro
Canfrán-Duque, A., Casado, M. E., Pastor, Ó., Sánchez-Wandelmer, J., de la Peña, G., Lerma, M., Mariscal, P., Bracher, F., Lasunción, M. A., & Busto, R. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m026948 · Cited by 105
Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis
Adlakha, Y. K., Khanna, S., Singh, R., Singh, V. P., Agrawal, A., & Saini, N. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.301 · Cited by 109
Okamoto, K., Mori, Y., Komoda, Y., Okamoto, T., Okochi, M., Takeda, M., Suzuki, T., Moriishi, K., & Matsuura, Y. (2008) · Journal of Virology · doi:10.1128/jvi.00306-08 · Cited by 105
Gu, W., Yan, H., Winters, K. A., Komorowski, R., Vonderfecht, S. L., Atangan, L. I., Sivits, G. N., Hill, D., Yang, J., Bi, V., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157685 · Cited by 105
Davidson, M. D., Ballinger, K. R., & Khetani, S. R. (2016) · Scientific Reports · doi:10.1038/srep28178 · Cited by 100
Ye, Y., Xu, H., Xie, Z., Wang, L., Sun, Y., Yang, H., Hu, D., & Mao, Y. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.596285 · Cited by 107
Betancor, M. B., Sprague, M., Montero, D., Usher, S. L., Sayanova, O. V., Campbell, P., Napier, J. A., Caballero, M. J., Izquierdo, M. S., & Tocher, D. R. (2016) · Lipids · doi:10.1007/s11745-016-4191-4 · Cited by 105
He, L., Simmen, F. A., Mehendale, H. M., Ronis, M. J. J., & Badger, T. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510724200 · Cited by 106
Malformation syndromes due to inborn errors of cholesterol synthesis
Porter, F. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16386 · Cited by 105
Inoue, T., Inoguchi, T., Sonoda, N., Hendarto, H., Makimura, H., Sasaki, S., Yokomizo, H., Fujimura, Y., Miura, D., & Takayanagi, R. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.026 · Cited by 103
Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice
Benetti, E., Mastrocola, R., Chiazza, F., Nigro, D., D’Antona, G., Bordano, V., Fantozzi, R., Aragno, M., Collino, M., & Minetto, M. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189707 · Cited by 107
Yao, H., Tao, X., Xu, L., Qi, Y., Yin, L., Han, X., Xu, Y., Zheng, L., & Peng, J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.017 · Cited by 102
Bioactive compounds from herbal medicines to manage dyslipidemia
Ji, X., Shi, S., Liu, B., Shan, M., Tang, D., Zhang, W., Zhang, Y., Zhang, L., Zhang, H., Lu, C. C., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109338 · Cited by 107
Miller, D. M., McCauley, K. F., & Dunham‐Snary, K. J. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70132 · Cited by 131
Seo, Y., Chong, H. K., Infante, A. M., Im, S., Xie, X. S., & Osborne, T. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904246106 · Cited by 106
Fernø, J., Vik‐Mo, A. O., Jassim, G., Håvik, B., Berge, K., Skrede, S., Gudbrandsen, O. A., Waage, J. E. R., Lunder, N., Mørk, S. J., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1370-x · Cited by 107
Beyea, M. M., Heslop, C., Sawyez, C. G., Edwards, J. Y., Markle, J., Hegele, R. A., & Huff, M. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m611063200 · Cited by 104
Clues to Neuro-Degeneration in Niemann-Pick Type C Disease from Global Gene Expression Profiling
Reddy, J. V., Ganley, I. G., & Pfeffer, S. R. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000019 · Cited by 104
Li, T.-T., Liu, Y.-Y., Wan, X.-Z., Huang, Z.-R., Liu, B., & Zhao, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103075 · Cited by 103
ERp57 Modulates STAT3 Signaling from the Lumen of the Endoplasmic Reticulum
Coe, H., Jung, J., Groenendyk, J., Prins, D., & Michalak, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.054015 · Cited by 103
Yan, H., Potu, R. B., Lu, H., de Almeida, V. V., Stewart, T. S., Ragland, D., Armstrong, A. P., Adeola, O., Nakatsu, C. H., & Ajuwon, K. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059581 · Cited by 109
Lu, Y., Zhou, W., Wei, L., Li, J., Jia, J., Li, F., Smith, S. M., & Xu, J. (2014) · Biotechnology for Biofuels · doi:10.1186/1754-6834-7-81 · Cited by 103
Lipids, inflammasomes, metabolism, and disease
Anand, P. (2020) · Immunological Reviews · doi:10.1111/imr.12891 · Cited by 108
Cariello, M., Piccinin, E., & Moschetta, A. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.01.012 · Cited by 108
Jia, Y., Yan, Q., Zheng, Y., Li, L., Zhang, B., Chang, Z., Wang, Z., Tang, H., Qin, Y., & Guan, X. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02449-4 · Cited by 106
Griffin, J. L., Bonney, S. A., Mann, C., Hebbachi, A. M., Gibbons, G. F., Nicholson, J. K., Shoulders, C. C., & Scott, J. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00158.2003 · Cited by 103
LeBlanc, S. E., Srinivasan, R., Ferri, C., Mager, G. M., Gillian‐Daniel, A. L., Wrabetz, L. G., & Svaren, J. P. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03056.x · Cited by 103
Albarado, D. C., McClaine, J. W., Stephens, J. M., Mynatt, R. L., Ye, J., Bannon, A. W., Richards, W. G., & Butler, A. A. (2003) · Endocrinology · doi:10.1210/en.2003-0452 · Cited by 103
Hammond, L. E., Neschen, S., Romanelli, A. J., Cline, G. W., Ilkayeva, O., Shulman, G. I., Muoio, D. M., & Coleman, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503181200 · Cited by 104
Effect of Weight Loss on LDL and HDL Kinetics in the Metabolic Syndrome
Ng, T. W., Watts, G. F., Barrett, P. H. R., Rye, K., & Chan, D. C. (2007) · Diabetes Care · doi:10.2337/dc07-0768 · Cited by 103
Miyata, S., Inoue, J., Shimizu, M., & Sato, R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.656975 · Cited by 101
Shibabaw, T. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03965-7 · Cited by 108
Rong, S., Xia, M., Vale, G., Wang, S., Kim, C.-W., Li, S., McDonald, J. G., Radhakrishnan, A., & Horton, J. D. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.01.011 · Cited by 102
Self-citationLange, Y., Ory, D. S., Ye, J., Lanier, M. H., Hsu, F., & Steck, T. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706967200 · Cited by 104
Localization and regulation of SR-BI in membrane rafts of HepG2 cells
Rhainds, D., Bourgeois, P., Bourret, G., Huard, K., Falstrault, L., & Brissette, L. (2004) · Journal of Cell Science · doi:10.1242/jcs.01182 · Cited by 102
Hellard, S. L., Theisen, F., Haberhausen, M., Raeder, M. B., Fernø, J., Gebhardt, S., Hinney, A., Remschmidt, H., Krieg, J. C., Mehler‐Wex, C., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002133 · Cited by 105
PKA/AMPK signaling in relation to adiponectin’s antiproliferative effect on multiple myeloma cells
Medina, E. A., Oberheu, K., Polusani, S. R., Ortega, V., Velagaleti, G. V. N., & Oyajobi, B. O. (2014) · Leukemia · doi:10.1038/leu.2014.112 · Cited by 104
Haczeyni, F., Wang, H., Barn, V., Mridha, A. R., Yeh, M. M., Haigh, W. G., Ioannou, G. N., Choi, Y., McWherter, C. A., Teoh, N., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1072 · Cited by 101
The cellular function of SCAP in metabolic signaling
Lee, S. H., Lee, J.-H., & Im, S.-S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0430-0 · Cited by 96
Yang, J., Craddock, L., Hong, S., & Liu, Z. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22024 · Cited by 107
Lerat, H., Kammoun, H. L., Hainault, I., Mérour, E., Higgs, M. R., Callens, C., Lemon, S. M., Foufelle, F., & Pawlotsky, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019810 · Cited by 101
Tamehiro, N., Shigemoto‐Mogami, Y., Kakeya, T., Okuhira, K., Suzuki, K., Sato, R., Nagao, T., & Nishimaki‐Mogami, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701228200 · Cited by 104
Flint, O. P., Noor, M. A., Hruz, P. W., Hylemon, P. B., Yarasheski, K. E., Kotler, D. P., Parker, R. A., & Bellamine, A. (2009) · Toxicologic Pathology · doi:10.1177/0192623308327119 · Cited by 101
Shechter, I., Dai, P., Huo, L., & Guan, G. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300285-jlr200 · Cited by 103
Choe, S. S., Choi, A. H., Lee, J.-W., Kim, K. H., Chung, J.-J., Park, J., Lee, K., Park, K., Lee, I. K., & Kim, J. B. (2007) · Diabetes · doi:10.2337/db06-1059 · Cited by 101
Amyloid precursor protein controls cholesterol turnover needed for neuronal activity
Pierrot, N., Tyteca, D., D’Auria, L., Dewachter, I., Gailly, P. L., Hendrickx, A., Tasiaux, B., Haylani, L. E., Muls, N., N’Kuli, F., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202215 · Cited by 103
Yeh, M. W., Cole, A. L., Choi, J., Liu, Y., Tulchinsky, D., Qiao, J.-H., Fishbein, M. C., Dooley, A. N., Hovnanian, T., Mouillesseaux, K. P., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000146030.53089.18 · Cited by 101
Zhou, H., Gurley, E. C., Brimson, S. J., Ding, H., Fang, Y., Xu, Z., Pandak, W. M., & Hylemon, P. B. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00182.2006 · Cited by 101
Bowman, T. A., O’Keeffe, K. R., D’Aquila, T., Yan, Q. W., Griffin, J. D., Killion, E. A., Salter, D. M., Mashek, D. G., Buhman, K. K., & Greenberg, A. S. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.01.001 · Cited by 100
Coleman, R. (2019) · Journal of Lipid Research · doi:10.1194/jlr.s091843 · Cited by 98
Andersen, M. E., Hagenbuch, B., Apte, U. M., Corton, J. C., Fletcher, T., Lau, C. S., Roth, W. L., Staels, B., Vega, G. L., M.A., H. J. C. I., et al. (2021) · Toxicology · doi:10.1016/j.tox.2021.152845 · Cited by 104
Positive Effects of Physical Activity on Insulin Signaling
Małkowska, P. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060327 · Cited by 126
Zhang, Z., Li, B., Meng, X.-J., Yao, S., Jin, L., Yang, J., Wang, J., Zhang, H., Zhang, Z., Cai, D., et al. (2016) · Scientific Reports · doi:10.1038/srep20848 · Cited by 99
Can LDL cholesterol be too low? Possible risks of extremely low levels
OLSSON, A. G., Angelin, B., Assmann, G., Binder, C. J., Björkhem, I., Cedazo-Mı́nguez, Á., Cohen, J. C., von Eckardstein, A., Farinaro, E., Müller‐Wieland, D., et al. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12614 · Cited by 102
Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer
Du, T., Sikora, M. J., Levine, K. M., Tasdemir, N., Riggins, R. B., Wendell, S. G., Houten, B. V., & Oesterreich, S. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1041-8 · Cited by 99
Wout, A. B. V. ’., Swain, J. V., Schindler, M., Rao, U., Pathmajeyan, M. S., Mullins, J. I., & Kirchhoff, F. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.10053-10058.2005 · Cited by 99
Sánchez, J., Palou, A., & Picó, C. (2009) · Endocrinology · doi:10.1210/en.2009-0466 · Cited by 98
C/EBPs: recipients of extracellular signals through proteome modulation
Nerlov, C. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.02.002 · Cited by 97
Nlrp3 is a key modulator of diet-induced nephropathy and renal cholesterol accumulation
Bakker, P. J., Butter, L. M., Kors, L., Teske, G. J. D., Aten, J., Sutterwala, F. S., Florquin, S., & Leemans, J. C. (2013) · Kidney International · doi:10.1038/ki.2013.503 · Cited by 98
Motamed, M., Zhang, Y., Wang, M. L., Seemann, J., Kwon, H. J., Goldstein, J. L., & Brown, M. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238311 · Cited by 98
Self-citationFucoidan improves serum lipid levels and atherosclerosis through hepatic SREBP-2-mediated regulation
Park, J., Yeom, M., & Hahm, D. (2016) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2016.03.007 · Cited by 98
Aberrant lipid metabolism in cancer cells – the role of oncolipid‐activated signaling
Ray, U., & Roy, S. S. (2017) · FEBS Journal · doi:10.1111/febs.14281 · Cited by 96
An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer
Longo, J., Mullen, P., Yu, R., van Leeuwen, J. E., Masoomian, M., Woon, D. T. S., Wang, Y. Z., Chen, E. X., Hamilton, R. J., Sweet, J., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.04.003 · Cited by 100
Mansoori, S., Ho, M. Y., Ng, K. K., & Cheng, K. K. Y. (2024) · Obesity Reviews · doi:10.1111/obr.13856 · Cited by 110
Endoplasmic reticulum stress and lipid dysregulation
Colgan, S. M., Al‐Hashimi, A., & Austin, R. C. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001742 · Cited by 97
Kim, Y., Shin, H.-T., Seo, Y., Byun, H., Yoon, S.-H., Lee, I., Hyun, D., Chung, H. Y., & Yoon, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.120386 · Cited by 102
Sumi, K., Tanaka, T., Uchida, A., Magoori, K., Urashima, Y., Ohashi, R., Ohguchi, H., Okamura, M., Kudo, H., Daigo, K., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01894-06 · Cited by 98
Ma, Y., Gao, M., & Liu, D. (2016) · Scientific Reports · doi:10.1038/srep26242 · Cited by 98
Bile acids: From digestion to cancers
Baptissart, M., Vega, A., Maqdasy, S., Caira, F., Baron, S., Lobaccaro, J.-M. A., & Volle, D. H. (2013) · Biochimie · doi:10.1016/j.biochi.2012.06.022 · Cited by 97
Zhang, H., Yan, S., Khambu, B., Ma, F., Li, Y., Chen, X., Martina, J. A., Puertollano, R., Li, Y., Chalasani, N., et al. (2018) · Autophagy · doi:10.1080/15548627.2018.1490850 · Cited by 96
Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage
Kou, Y., Geng, F., & Guo, D. (2022) · Biomedicines · doi:10.3390/biomedicines10081943 · Cited by 98
SIRT1/SREBPs-mediated regulation of lipid metabolism
Shen, S., Shen, M., Kuang, L., Yang, K., Wu, S., Liu, X., Wang, Y., & Wang, Y. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.107037 · Cited by 98
A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration
Ishihara, M., Kujiraoka, T., Iwasaki, T., Nagano, M., Takano, M., Ishii, J., Tsuji, M., Ide, H., Miller, I. P., Miller, N. E., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.d500018-jlr200 · Cited by 100
Mullen, E., Brown, R. M., Osborne, T. F., & Shay, N. F. (2004) · Journal of Nutrition · doi:10.1093/jn/134.11.2942 · Cited by 97
Schupp, M., Chen, F., Briggs, E. R., Rao, S. J., Pelzmann, H. J., Pessentheiner, A. R., Bogner‐Strauß, J. G., Lazar, M. A., Baldwin, D. A., & Prokesch, A. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-758 · Cited by 103
Li, S., Monroig, Ó., Wang, T., Yuan, Y., Navarro, J. C., Hontoria, F., Liao, K., Tocher, D. R., Mai, K., Xu, W., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02646-8 · Cited by 96
Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation
de la Roche, M., Hamilton, C., Mortensen, R., Jeyaprakash, A. A., Ghosh, S., & Anand, P. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201709057 · Cited by 102
Bakhtiarizadeh, M. R., Salehi, A., Alamouti, A. A., Abdollahi-Arpanahi, R., & Salami, S. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-45665-3 · Cited by 94
Intersection of the unfolded protein response and hepatic lipid metabolism
Lee, A., & Glimcher, L. H. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0049-8 · Cited by 97
Malformation syndromes due to inborn errors of cholesterol synthesis
Porter, F. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216386 · Cited by 96
Isken, F., Klaus, S., Petzke, K. J., Loddenkemper, C., Pfeiffer, A. F. H., & Weickert, M. O. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00515.2009 · Cited by 95
Yu, D., Tomasiewicz, J. L., Yang, S. E., Miller, B. R., Wakai, M. H., Sherman, D. S., Cummings, N. E., Baar, E. L., Brinkman, J. A., Syed, F. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.084 · Cited by 98
Martínez, B. A., Hoyle, R. G., Yeudall, S., Granade, M. E., Harris, T. E., Castle, J. D., Leitinger, N., & Bland, M. L. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009192 · Cited by 98
Carobbio, S., Hagen, R. M., Lelliott, C. J., Slawik, M., Medina‐Gómez, G., Tan, C.-Y., Sicard, A., Atherton, H. J., Barbarroja, N., Bjursell, M., et al. (2013) · Diabetes · doi:10.2337/db12-1748 · Cited by 92
REPTOR and REPTOR-BP Regulate Organismal Metabolism and Transcription Downstream of TORC1
Tiebe, M., Lutz, M., Garza, A. D. L., Buechling, T., Boutros, M., & Teleman, A. A. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.03.013 · Cited by 95
Molecular features of bile salt hydrolases and relevance in human health
Chand, D., Avinash, V. S., Yadav, Y., Pundle, A. V., Suresh, C. G., & Ramasamy, S. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.09.024 · Cited by 98
Chen, K., Chen, X., Xue, H., Zhang, P., Fang, W., Chen, X., & Ling, W. (2019) · Food & Function · doi:10.1039/c8fo01236a · Cited by 95
Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism
Sasako, T., Ohsugi, M., Kubota, N., Itoh, S., Okazaki, Y., Terai, A., Kubota, T., Yamashita, S., Nakatsukasa, K., Kamura, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08591-6 · Cited by 92
The role of lipotoxicity in kidney disease: From molecular mechanisms to therapeutic prospects
Ren, L., Cui, H., Wang, Y., Ju, F., Cai, Y., Gang, X., & Wang, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114465 · Cited by 104
Bursill, C. A., & Roach, P. D. (2006) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf051736o · Cited by 93
Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice
Park, T., Panek, R. L., Rekhter, M. D., Mueller, S. B., Rosebury, W. S., Robertson, A. W., Hanselman, J. C., Kindt, E. K., Homan, R., & Karathanasis, S. K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.029 · Cited by 95
Wang, J., Fang, X., & Liang, W. P. (2012) · ACS Nano · doi:10.1021/nn300571c · Cited by 93
You, Y., Li, W., Zhang, S., Hu, B., Li, Y., Li, H., Tang, H., Li, Q., Guan, Y., Liu, L., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.038 · Cited by 93
Bioavailability of Fat-Soluble Vitamins and Phytochemicals in Humans: Effects of Genetic Variation
Borel, P., & Desmarchelier, C. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051628 · Cited by 95
Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma
Ahmad, F., Sun, Q., Patel, D., & Stommel, J. M. (2019) · Cancers · doi:10.3390/cancers11020146 · Cited by 96
Hao, Z., Zhang, Z., Lu, D., Ding, B., Shu, L., Zhang, Q., & Wang, C. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00058 · Cited by 94
p38 Mitogen-activated Protein Kinase Plays an Inhibitory Role in Hepatic Lipogenesis
Xiong, Y., Collins, Q. F., An, J., Lupo, E. G., Liu, H. Y., Liu, D., Robidoux, J., Liu, Z., & Cao, W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606742200 · Cited by 93
Oka, S., Yoshihara, E., Bizen-Abe, A., Liu, W., Watanabe, M., Yodoi, J., & Masutani, H. (2008) · Endocrinology · doi:10.1210/en.2008-0646 · Cited by 93
Metadata
- Authors
- Horton, J. D., Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Horton, Jay D.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-05-01
- Volume
- 109
- Issue
- 9
- Pages
- 1125-1131
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4252021281
- Cited by
- 4,092
- References
- 47
- Citations by year
- 2026: 149 · 2025: 178 · 2024: 191 · 2023: 215 · 2022: 211 · 2021: 210 · 2020: 263 · 2019: 217 · 2018: 212 · 2017: 206 · 2016: 199 · 2015: 180 · 2014: 184 · 2013: 180 · 2012: 142
- FWCI
- 104.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- W. M. Keck Foundation
- American Heart Association
- National Institutes of Health (HL20948)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- SREBP, cholesterol biosynthesis, fatty acid synthesis, lipid homeostasis, liver, transcription factors, NADPH, triglyceride synthesis, phospholipid synthesis, bile micelles, knockout mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
